B8F.DE stock opened pre-market on 03 Mar 2026 at EUR 6.80 after a dramatic intraday move showing a 2,000.00% change and 45,797 shares traded. This unusually high volume versus an average of 605.00 signals outsized retail or block activity on XETRA in Germany. We assess why Biofrontera AG (B8F.DE) moved, which financial metrics matter, and what the Meyka AI model and technicals imply for traders watching a high-volume mover.

Market action and liquidity: B8F.DE stock volume spike

B8F.DE stock recorded 45,797 shares traded pre-market, about 75.70 times average volume, driven by a move from a previous close EUR 0.32 to EUR 6.80. The price range on the session shows a low of EUR 0.30 and a high of EUR 6.80, which highlights extreme intraday volatility on XETRA.

Company profile and product pipeline: B8F.DE stock fundamentals

Biofrontera AG (B8F.DE) is a Germany-listed dermatology biotech with headline products Ameluz and the BF-RhodoLED lamp and operations in the United States, Europe, and Israel. For more on the company and pipeline see the corporate site Biofrontera.

Valuation and financials: B8F.DE stock metrics

Key trailing metrics show EPS -0.21, P/E -32.40, and market cap EUR 20,673,478.00 based on 3,038,430 shares outstanding. Price-to-sales stands at 0.64 and price-to-book at 21.73, while the current ratio is 1.76, which signals adequate short-term liquidity but a stretched valuation vs book value.

Technical, sector context and Meyka grade: B8F.DE stock analysis

The 50-day average is EUR 6.53 and the 200-day average is EUR 9.19, placing the current price below long-term trend lines and above short-term momentum. Meyka AI rates B8F.DE with a score of 62.64 out of 100 — Grade B, HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Risks and catalysts: B8F.DE stock outlook

Immediate risks include thin order book effects and rapid swings caused by low float, given average volume 605.00 and shares outstanding 3,038,430. Catalysts that could reprice the stock include regulatory updates, product approvals, or material partnership news.

Trading notes and sources: B8F.DE stock news and data

Traders should note wide bid-ask spreads and the potential for trade cancellations in volatile sessions on XETRA; check live quotes before entering positions. Market data referenced includes the exchange listing and intraday quote on Börse Frankfurt source and company disclosures source.

Final Thoughts

Key takeaways: B8F.DE stock moved to EUR 6.80 pre-market on 03 Mar 2026 with very high volume (45,797) and a relative volume of 75.70, marking it as a high-volume mover on XETRA in Germany. Fundamentals show EPS -0.21 and P/E -32.40, while price-to-sales 0.64 suggests revenue cover for valuation but price-to-book 21.73 flags premium pricing versus book. Meyka AI’s forecast model projects a 12-month target of EUR 9.00, implying an upside of 32.35% versus the current EUR 6.80, though forecasts are model-based projections and not guarantees. Given the Meyka AI grade B (HOLD), traders should weigh the upside case against liquidity risks and monitor regulatory or corporate updates that could change momentum. For real-time data, view the Meyka stock page for B8F.DE and confirm order book depth before trading.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.